Since its development in the late 1990s and early 2000s, IDD Therapy treatment has had a commitment to evidence-based medicine.
Overall, the evidence shows that IDD Therapy to be as effective or more effective than manual therapy and exercise and more effective than traditional traction. Below are various studies and articles.
Commitment to Evidence-Based Medicine
IDD Therapy providers all use internationally recognised-research tools to track and monitor patient progress (Oswestry Disability Index and Visual Analogue Scale) as well as objective outcome measures.
In addition, the IDD Therapy treatment is unique as the ONLY physiotherapuetic device to have these measures built into the software. All treatments are recorded and thus IDD Therapy provides a duplicable and measurable programme of treatment.
There is no such thing as a cure-all for back pain sadly, however with IDD Therapy there is a genuine commitment to evidence-based best practice which is backed up by the recording capabilities.
The following studies give an overview of different aspects of IDD Therapy treatment. The first article here is by Sheffield Physiotherapist John Wood.
This article published in Spinal Surgery News goes into detail about the mechanisms of IDD Therapy and makes reference to elements of the studies. It provides a useful overview for practitioners wanting to get a better understanding of IDD Therapy.
This last study was the study which paved the way for decompression by first measuring the distraction of targeted spinal segments. It also compared the new decompression to traditional traction.
Whilst small in nature, it was significant in it’s implications for the changes in mechanical spine treatment which followed.
All IDD Therapy clinics have a commitment to evidence-based practice. There are of course many variables in treating back pain and no two conditions are the same. However all clinics use research tools and objective outcome measures and whilst busy in private practice, are encouraged to audit their outcomes. A growing number of IDD Therapy providers now use ViMove gyroscopic movement sensors to measure and track changes in function, to the nearest degree.
It is expected that more clinics will incorporate ViMove to help patients during their treatment and to gain further insights into treatment planning.